MoonLake Immunotherapeutics(MLTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MLTX MoonLake Immunotherapeutics

Market Closed 01-16 16:00:00 EST

16.76

+0.41

+2.51%

盘后16.75

-0.01-0.06%

19:58 EST

High16.88	Low16.18	Vol1.46M
Open16.39	D1 Closing16.35	Amplitude4.28%
Mkt Cap1.20B	Tradable Cap677.37M	Total Shares71.37M
T/O24.30M	T/O Rate3.62%	Tradable Shares40.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MLTX","market":"US","secType":"STK","nameCN":"MoonLake Immunotherapeutics","latestPrice":16.76,"timestamp":1768597200000,"preClose":16.35,"halted":0,"volume":1463500,"hourTrading":{"tag":"盘后","latestPrice":16.75,"preClose":16.76,"latestTime":"19:58 EST","volume":16440,"amount":275441.3428,"timestamp":1768611496626},"delay":0,"floatShares":40415700,"shares":71373579,"eps":-3.328528,"marketStatus":"Market Closed","change":0.41,"latestTime":"01-16 16:00:00 EST","open":16.39,"high":16.88,"low":16.18,"amount":24304883.068,"amplitude":0.042813,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.328528,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1603166400000,"exchange":"NASDAQ","adjPreClose":16.35,"preHourTrading":{"tag":"盘前","latestPrice":16.36,"preClose":16.35,"latestTime":"09:27 EST","volume":4697,"amount":77222.141689,"timestamp":1768573650683},"postHourTrading":{"tag":"盘后","latestPrice":16.75,"preClose":16.76,"latestTime":"19:58 EST","volume":16440,"amount":275441.3428,"timestamp":1768611496626},"volumeRatio":0.281068,"impliedVol":1.1508,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/MLTX/tweets","defaultTab":"tweets","newsList":[{"id":"2603647246","title":"MoonLake Immunotherapeutics downgraded to Sell from Neutral at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647246","media":"TIPRANKS","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603647246?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:10","pubTimestamp":1768428614,"startTime":"0","endTime":"0","summary":"Goldman Sachs downgraded MoonLake Immunotherapeutics (MLTX) to Sell from Neutral with a price target of $10, up from $8. While the firm believes so...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moonlake-immunotherapeutics-downgraded-to-sell-from-neutral-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moonlake-immunotherapeutics-downgraded-to-sell-from-neutral-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLTX"],"gpt_icon":0},{"id":"2602305207","title":"MoonLake Immunotherapeutics Shares Rise After BTIG Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2602305207","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602305207?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:13","pubTimestamp":1767986001,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics  shares were up 25% in recent Friday trading after BTIG Research upgraded the stock to buy from neutral, with a price target of $24.Trading volume stood at over 9.8 million shares, versus the daily average of about 2.7 million.Price: 17.92, Change: +3.58, Percent Change: +24.97","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLTX"],"gpt_icon":0},{"id":"2602376280","title":"BTIG Research Upgrades MoonLake Immunotherapeutics to Buy From Neutral, $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376280?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:22","pubTimestamp":1767964927,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics (MLTX) has an average rating of overweight and mean price target of $19.53, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLTX"],"gpt_icon":0},{"id":"2602137897","title":"MoonLake Immunotherapeutics : Btig Raises to Buy From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2602137897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602137897?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:00","pubTimestamp":1767960022,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA14Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2602327023","title":"MoonLake price target raised to $32 from $26 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2602327023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602327023?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:15","pubTimestamp":1767957353,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $32 from $26 and keeps a Buy rating on the shares. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moonlake-price-target-raised-to-32-from-26-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moonlake-price-target-raised-to-32-from-26-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2602327672","title":"MoonLake Immunotherap Raised to Buy From Neutral by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2602327672","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602327672?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:07","pubTimestamp":1767956820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MLTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 09, 2026 06:07 ET (11:07 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2602397007","title":"MoonLake Immunotherapeutics: HS Regulatory De-Risking and 2026 Inflammatory Disease Catalysts Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602397007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602397007?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:45","pubTimestamp":1767901518,"startTime":"0","endTime":"0","summary":"Needham analyst Serge Belanger maintained a Buy rating on MoonLake Immunotherapeutics today and set a price target of $20.00. Serge Belanger has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/moonlake-immunotherapeutics-hs-regulatory-de-risking-and-2026-inflammatory-disease-catalysts-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/moonlake-immunotherapeutics-hs-regulatory-de-risking-and-2026-inflammatory-disease-catalysts-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLTX"],"gpt_icon":0},{"id":"2602397872","title":"BUZZ-U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, Gap","url":"https://stock-news.laohu8.com/highlight/detail?id=2602397872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602397872?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:07","pubTimestamp":1767899243,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-DoorDash, Duolingo, GapEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nL6N3Y90Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","AMH","KTOS","JCAP","TYL","CDE","SMPL","NEOG","MPC","ACI","LUMN","KR","DHI","AA","GAP","TGT","VLO","HL","DPZ","CNC","NOC","DRI","WRB","BW","RTX","NEM","OMDA","DASH","SCCO","SHOO","SKT","OTTR","EAT","MLTX","BX","VOYG","COMP","DUOL","DLR","SHAK","GM","HELE","TFX"],"gpt_icon":1},{"id":"2602639987","title":"MoonLake Immunotherapeutics Up Nearly 26%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2602639987","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602639987?lang=en_us&edition=fundamental","pubTime":"2026-01-09 00:41","pubTimestamp":1767890460,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics Class A  is currently at $14.20, up $2.91 or 25.73%. --Would be highest close since Dec. 16, 2025, when it closed at $15.34. --On pace for largest percent increase since June 26, 2023, when it rose 77.55%. --Currently up two consecutive days; up 27.08% over this period. --Down 77.77% from its all-time closing high of $63.86 on Feb. 12, 2024. --Down 70.53% from 52 weeks ago , when it closed at $48.17. --Down 77.1% from its 52-week closing high of $61.99 on Sept. 26, 2025. --Traded as high as $16.39; highest intraday level since Sept. 26, 2025, when it hit $62.75. --Up 45.17% at today's intraday high; largest intraday percent increase since June 26, 2023, when it rose as much as 102.18%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2601570393","title":"MoonLake (MLTX): De-Risked HS Pathway and Multi-Indication Pipeline Support Attractive Risk/Reward and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2601570393","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601570393?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:55","pubTimestamp":1767884134,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on MoonLake Immunotherapeutics, with a price target of $33.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/moonlake-mltx-de-risked-hs-pathway-and-multi-indication-pipeline-support-attractive-risk-reward-and-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/moonlake-mltx-de-risked-hs-pathway-and-multi-indication-pipeline-support-attractive-risk-reward-and-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLTX"],"gpt_icon":0},{"id":"2601706398","title":"MoonLake Immunotherapeutics Shares Soar 32..9% as US FDA Clears Path for Skin Disease Drug Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601706398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601706398?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:47","pubTimestamp":1767883633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y911K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2601360407","title":"BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, Nike","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360407","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601360407?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:21","pubTimestamp":1767882071,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, NikeEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nL6N3Y90NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOUS","SHOO","MLTX","LU0396098781.USD","NEOG","SCCO","COMP","LU0868494708.USD","STZ","HL","KTOS","ABBV","LU1267930227.SGD","RVMD","PHAT","89988","LU0577902298.EUR","TFX","DRI","VLO","RTX","BK4596","CDE","APD","IE00B4R5TH58.HKD","LNN","NOC","GM","ALBmain","HELE","MPC","AA","JCAP","TYL","LU2097828805.USD","NKE","F","NEM","HBBD.SI","GLUE","BW","VNDA"],"gpt_icon":1},{"id":"2601362465","title":"Biotech Stock MoonLake Surges 33% After Announcing Positive Outcome From Type B Meeting With U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362465","media":"Reuters","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362465?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:41","pubTimestamp":1767879671,"startTime":"0","endTime":"0","summary":"$MoonLake Immunotherapeutics(MLTX)$ climbed 28% in the premarket on Thursday after the company said that the FDA will not require additional clinical trials to support a marketing application for its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nRSDB3Y62:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Biotech Stock MoonLake Announces Positive Outcome From Type B Meeting With US FDA","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2601362085","title":"BUZZ-MoonLake soars as FDA clears path for skin disease drug filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362085?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:38","pubTimestamp":1767879517,"startTime":"0","endTime":"0","summary":"BUZZ-MoonLake soars as FDA clears path for skin disease drug filing** Shares of Swiss biotech MoonLake Immunotherapeutics MLTX.O rise 37.6% to $15.53 premarket** Co says it has received positive feedback from the U.S. FDA that will allow the co to move forward with its BLA  application for sonelokimab without more trials** Co's sonelokimab targets hidradenitis suppurativa, a painful chronic skin condition causing lesions and scarring - MLTX** The drug showed better outcomes vs placebo in over 1,000 patients, says co** Co plans BLA submission in the second half of 2026** A BLA or Biologics License Application is a formal request to the FDA seeking approval to market a biologic drug in the U.S. after demonstrating safety and effectiveness** As of last close, stock down ~14% over the past year  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nL4N3Y90XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2601626353","title":"BRIEF-Moonlake Immunotherapeutics Announces Positive Outcome From Type B Meeting With U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2601626353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601626353?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:26","pubTimestamp":1767878764,"startTime":"0","endTime":"0","summary":"BRIEF-Moonlake Immunotherapeutics Announces Positive Outcome From Type B Meeting With U.S. FDA Jan 8 (Reuters) - MoonLake Immunotherapeutics MLTX.O:MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES POSITIVE OUTCO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7WL1QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2601362340","title":"MoonLake Immunotherapeutics Shares Rise 35% Premarket After Meeting With US FDA Regarding Co's Skin Disease Drug Marketing Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362340?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:22","pubTimestamp":1767878577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nL4N3Y90WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2601628313","title":"MoonLake provides update following positive feedback from U.S. FDA for SLK","url":"https://stock-news.laohu8.com/highlight/detail?id=2601628313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601628313?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:16","pubTimestamp":1767878213,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics (MLTX) provided an update following the positive feedback received from the U.S. Food and Drug Administration, FDA, reg...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moonlake-provides-update-following-positive-feedback-from-u-s-fda-for-slk-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moonlake-provides-update-following-positive-feedback-from-u-s-fda-for-slk-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"1116502352","title":"Stock Track | MoonLake Immunotherapeutics Soars 43.58% in Pre-Market on FDA Feedback and Investor Day Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1116502352","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116502352?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:14","pubTimestamp":1767878080,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics (MLTX) surged 43.58% in pre-market trading on Thursday, driven by positive developments including FDA feedback and plans for an Investor Day.The company announced a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MLTX"],"gpt_icon":0},{"id":"2601332364","title":"MoonLake Immunotherapeutics to Host Investor Day to Discuss FDA Feedback and Reveal New Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2601332364","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601332364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:01","pubTimestamp":1767877271,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics will host an Investor Day on February 23, 2026, at 8 am EST / 2 pm CET to discuss outcomes from a recent Type B FDA meeting, share new clinical data for SLK across indications, and provide details on the company's catalyst calendar for 2026 and beyond.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moonlake Immunotherapeutics published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"33791b051befbfd8525af904615f530c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL1Kl8hV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","SG9999014039.USD","BK4139","LU2095319765.USD","SG9999014013.SGD","BK4112","LU0314104364.USD","MLTX","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","BK4585"],"gpt_icon":0},{"id":"2601648243","title":"MoonLake Immunotherapeutics - Plans Bla Submission for Slk in Hs in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601648243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601648243?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA7WL1QM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moonlaketx.com","stockEarnings":[{"period":"1week","weight":-0.0936},{"period":"1month","weight":0.2014},{"period":"3month","weight":0.8377},{"period":"6month","weight":-0.6843},{"period":"1year","weight":-0.5959},{"period":"ytd","weight":0.2716}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.024963},{"month":2,"riseRate":0.4,"avgChangeRate":0.077053},{"month":3,"riseRate":0.6,"avgChangeRate":0.026866},{"month":4,"riseRate":0.2,"avgChangeRate":-0.112596},{"month":5,"riseRate":0.4,"avgChangeRate":0.086858},{"month":6,"riseRate":0.8,"avgChangeRate":0.175967},{"month":7,"riseRate":0.6,"avgChangeRate":0.073307},{"month":8,"riseRate":0.6,"avgChangeRate":0.090179},{"month":9,"riseRate":0.4,"avgChangeRate":-0.166769},{"month":10,"riseRate":0.6,"avgChangeRate":0.061028},{"month":11,"riseRate":0.666667,"avgChangeRate":0.098535},{"month":12,"riseRate":0.5,"avgChangeRate":0.079459}],"exchange":"NASDAQ","name":"MoonLake Immunotherapeutics","nameEN":"MoonLake Immunotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MoonLake Immunotherapeutics(MLTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MoonLake Immunotherapeutics(MLTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MoonLake Immunotherapeutics,MLTX,MoonLake Immunotherapeutics股票,MoonLake Immunotherapeutics股票老虎,MoonLake Immunotherapeutics股票老虎国际,MoonLake Immunotherapeutics行情,MoonLake Immunotherapeutics股票行情,MoonLake Immunotherapeutics股价,MoonLake Immunotherapeutics股市,MoonLake Immunotherapeutics股票价格,MoonLake Immunotherapeutics股票交易,MoonLake Immunotherapeutics股票购买,MoonLake Immunotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MoonLake Immunotherapeutics(MLTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MoonLake Immunotherapeutics(MLTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}